Nick joined Intercytex as Chief Executive Officer in January 2005 having been a Non-Executive Director of the company since it was founded, and brings over 20 years of experience in commercialising biotechnology products. He was previously Chief Business Officer and a Board Director of Acambis plc (vaccines) which he joined in 1994. He was responsible for all commercial activities including IP management, licensing, corporate development, mergers/acquisitions and sales and marketing. In addition, he played a key role in the company’s flotation on the London Stock Exchange in 1995.

Prior to Acambis he worked for Porton International Ltd (biologicals) where he managed IP and commercial agreements with the company’s collaborators. Before Porton he worked for The PA Consultancy Group where he was a founder member of the Biotechnology Group in which he participated in over 50 European and international assignments. He started his business career with Unilever Research Ltd (consumer goods) as a chemical and biochemical engineer. Nick has a BSc in biochemistry from the University College of Wales, an MSc in biochemical engineering from University College, London and an MSc in the Management of Intellectual Property from QMW, London.